These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 25610760)

  • 1. Imaging of repeated episodes of demyelination and remyelination in multiple sclerosis.
    Brown RA; Narayanan S; Arnold DL
    Neuroimage Clin; 2014; 6():20-5. PubMed ID: 25610760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-Term Magnetization Transfer Ratio Evolution in Multiple Sclerosis White Matter Lesions.
    Zheng Y; Lee JC; Rudick R; Fisher E
    J Neuroimaging; 2018 Mar; 28(2):191-198. PubMed ID: 29076591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local magnetization transfer ratio signal inhomogeneity is related to subsequent change in MTR in lesions and normal-appearing white-matter of multiple sclerosis patients.
    Chen JT; Collins DL; Freedman MS; Atkins HL; Arnold DL;
    Neuroimage; 2005 May; 25(4):1272-8. PubMed ID: 15850745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measuring demyelination and remyelination in acute multiple sclerosis lesion voxels.
    Giacomini PS; Levesque IR; Ribeiro L; Narayanan S; Francis SJ; Pike GB; Arnold DL
    Arch Neurol; 2009 Mar; 66(3):375-81. PubMed ID: 19273757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetization transfer ratio measures in normal-appearing white matter show periventricular gradient abnormalities in multiple sclerosis.
    Liu Z; Pardini M; Yaldizli Ö; Sethi V; Muhlert N; Wheeler-Kingshott CA; Samson RS; Miller DH; Chard DT
    Brain; 2015 May; 138(Pt 5):1239-46. PubMed ID: 25823475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Segmentation of magnetization transfer ratio lesions for longitudinal analysis of demyelination and remyelination in multiple sclerosis.
    Brown RA; Narayanan S; Arnold DL
    Neuroimage; 2013 Feb; 66():103-9. PubMed ID: 23110887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal evaluation of demyelinated lesions in a multiple sclerosis model using ultrashort echo time magnetization transfer (UTE-MT) imaging.
    Guglielmetti C; Boucneau T; Cao P; Van der Linden A; Larson PEZ; Chaumeil MM
    Neuroimage; 2020 Mar; 208():116415. PubMed ID: 31811900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetization transfer ratio evolution with demyelination and remyelination in multiple sclerosis lesions.
    Chen JT; Collins DL; Atkins HL; Freedman MS; Arnold DL;
    Ann Neurol; 2008 Feb; 63(2):254-62. PubMed ID: 18257039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain damage as detected by magnetization transfer imaging is less pronounced in benign than in early relapsing multiple sclerosis.
    De Stefano N; Battaglini M; Stromillo ML; Zipoli V; Bartolozzi ML; Guidi L; Siracusa G; Portaccio E; Giorgio A; Sorbi S; Federico A; Amato MP
    Brain; 2006 Aug; 129(Pt 8):2008-16. PubMed ID: 16815879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Within-lesion differences in quantitative MRI parameters predict contrast enhancement in multiple sclerosis.
    Jurcoane A; Wagner M; Schmidt C; Mayer C; Gracien RM; Hirschmann M; Deichmann R; Volz S; Ziemann U; Hattingen E
    J Magn Reson Imaging; 2013 Dec; 38(6):1454-61. PubMed ID: 23554005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lesion remyelinating activity of GSK239512 versus placebo in patients with relapsing-remitting multiple sclerosis: a randomised, single-blind, phase II study.
    Schwartzbach CJ; Grove RA; Brown R; Tompson D; Then Bergh F; Arnold DL
    J Neurol; 2017 Feb; 264(2):304-315. PubMed ID: 27888416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetization transfer ratio in lesions rather than normal-appearing brain relates to disability in patients with multiple sclerosis.
    Amann M; Papadopoulou A; Andelova M; Magon S; Mueller-Lenke N; Naegelin Y; Stippich C; Radue EW; Bieri O; Kappos L; Sprenger T
    J Neurol; 2015 Aug; 262(8):1909-17. PubMed ID: 26041614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cortical Remyelination Is Heterogeneous in Multiple Sclerosis.
    Strijbis EMM; Kooi EJ; van der Valk P; Geurts JJG
    J Neuropathol Exp Neurol; 2017 May; 76(5):390-401. PubMed ID: 28521040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age independently affects myelin integrity as detected by magnetization transfer magnetic resonance imaging in multiple sclerosis.
    Newbould RD; Nicholas R; Thomas CL; Quest R; Lee JS; Honeyfield L; Colasanti A; Malik O; Mattoscio M; Matthews PM; Sormani MP; Waldman AD; Muraro PA
    Neuroimage Clin; 2014; 4():641-8. PubMed ID: 24936415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histogram analysis of quantitative T1 and MT maps from ultrahigh field MRI in clinically isolated syndrome and relapsing-remitting multiple sclerosis.
    Al-Radaideh A; Mougin OE; Lim SY; Chou IJ; Constantinescu CS; Gowland P
    NMR Biomed; 2015 Nov; 28(11):1374-82. PubMed ID: 26346925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Axonal injury in the cerebral normal-appearing white matter of patients with multiple sclerosis is related to concurrent demyelination in lesions but not to concurrent demyelination in normal-appearing white matter.
    Narayanan S; Francis SJ; Sled JG; Santos AC; Antel S; Levesque I; Brass S; Lapierre Y; Sappey-Marinier D; Pike GB; Arnold DL
    Neuroimage; 2006 Jan; 29(2):637-42. PubMed ID: 16126413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetization transfer ratio recovery in new lesions decreases during adolescence in pediatric-onset multiple sclerosis patients.
    Brown RA; Narayanan S; Banwell B; Arnold DL;
    Neuroimage Clin; 2014; 6():237-42. PubMed ID: 25379436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lesional magnetization transfer ratio: a feasible outcome for remyelinating treatment trials in multiple sclerosis.
    van den Elskamp IJ; Knol DL; Vrenken H; Karas G; Meijerman A; Filippi M; Kappos L; Fazekas F; Wagner K; Pohl C; Sandbrink R; Polman CH; Uitdehaag BM; Barkhof F
    Mult Scler; 2010 Jun; 16(6):660-9. PubMed ID: 20350960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantifying Remyelination Using χ-Separation in White Matter and Cortical Multiple Sclerosis Lesions.
    Müller J; Lu PJ; Cagol A; Ruberte E; Shin HG; Ocampo-Pineda M; Chen X; Tsagkas C; Barakovic M; Galbusera R; Weigel M; Schaedelin SA; Wang Y; Nguyen TD; Spincemaille P; Kappos L; Kuhle J; Lee J; Granziera C
    Neurology; 2024 Sep; 103(6):e209604. PubMed ID: 39213476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of outer cortical magnetisation transfer ratio abnormalities in multiple sclerosis clinical subgroups.
    Samson RS; Cardoso MJ; Muhlert N; Sethi V; Wheeler-Kingshott CA; Ron M; Ourselin S; Miller DH; Chard DT
    Mult Scler; 2014 Sep; 20(10):1322-30. PubMed ID: 24552746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.